Background Gliomas are the most common and aggressive tumors of the central nervous
system. A robust and widely used blood-based biomarker for glioma has not yet been …

Background In some malignant tumors, a high neutrophil-to-lymphocyte ratio (NLR) is
connected with unfavorable prognosis. Nevertheless, the prognostic value of the NLR in …

In some malignant tumours, the changes in neutrophil counts in relation to other blood cells
are connected with unfavourable prognosis. Nevertheless, the prognostic value of the …

Background: Inflammation plays an important role in tumorigenesis. Previous studies have
reported the prognostic value of several peripheral inflammatory markers in glioma patients …

Glioma is the most common malignant brain tumor and has high lethality. This tumor
generated a robust inflammatory response that results in the deterioration of the disease …

Purpose The aims of our retrospective study investigated the role of immune system in
glioblastoma (GBM), which is the most aggressive primary brain tumor in adults …

Background Some patients with glioblastoma multiforme (GBM) survive 3–5 years (or
longer) after diagnosis. The goal of this study was to identify differences between the long …

The effectiveness of tumor therapy, especially immunotherapy and oncolytic virotherapy,
critically depends on the activity of the host immune cells. However, various local and …

Objective: Although some meta-analyses have shown a correlation between a high
neutrophil-to-lymphocyte ratio (NLR) and low survival in patients with gliomas, their …

Objective This study evaluated the prognostic value of preoperative neutrophil to lymphocyte
ratio (NLR), platelet to lymphocyte ratio (PLR), and systemic immune inflammation index …